Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Trudeau

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Cancer|March 11, 2003
Factors influencing arm and axillary symptoms after treatment for node negative breast carcinomaKaren P L Yap, David R McCready, Steven Narod, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
RNA Disruption and Drug Response in Breast Cancer Primary Systemic TherapyKenneth Pritzker, Laura Pritzker, Daniele Generali, et al.
The Journal of Supportive Oncology|October 20, 2007
Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational studyChristopher M Booth, Mark Clemons, George Dranitsaris, et al.
Journal of the National Cancer Institute|May 17, 2023
Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practiceJacques Raphael, Lucie Richard, Melody Lam, et al.
Breast Cancer Research and Treatment|September 17, 2022
Impact of body mass index on survival in women receiving chemotherapy for early breast cancerRossanna C Pezo, Kelvin K W Chan, Danilo Giffoni M M Mata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2004
Bisphosphonate use for the management of breast cancer patients with bone metastases: a survey of Canadian Medical OncologistsSunil Verma, Danielle Kerr-Cresswell, George Dranitsaris, et al.
Breast Cancer Research and Treatment|January 22, 2008
Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancerJoanne Kotsopoulos, William W Zhang, Shiyu Zhang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 12, 2020
Prediction of breast cancer-related outcomes with the Edmonton Symptom Assessment Scale: A literature reviewLauren Milton, Tara Behroozian, Natalie Coburn, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline-Taxane Chemotherapy in Early HER-2 Negative Breast CancerDanilo Giffoni de Mello Morais Mata, Rossanna C Pezo, Kelvin K W Chan, et al.
Clinical Breast Cancer|September 7, 2024
Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant ChemotherapyNeda Stjepanovic, Sudhir Kumar, Katarzyna J Jerzak, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Cancer|March 11, 2003
Factors influencing arm and axillary symptoms after treatment for node negative breast carcinomaKaren P L Yap, David R McCready, Steven Narod, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
RNA Disruption and Drug Response in Breast Cancer Primary Systemic TherapyKenneth Pritzker, Laura Pritzker, Daniele Generali, et al.
The Journal of Supportive Oncology|October 20, 2007
Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational studyChristopher M Booth, Mark Clemons, George Dranitsaris, et al.
Journal of the National Cancer Institute|May 17, 2023
Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practiceJacques Raphael, Lucie Richard, Melody Lam, et al.
Breast Cancer Research and Treatment|September 17, 2022
Impact of body mass index on survival in women receiving chemotherapy for early breast cancerRossanna C Pezo, Kelvin K W Chan, Danilo Giffoni M M Mata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2004
Bisphosphonate use for the management of breast cancer patients with bone metastases: a survey of Canadian Medical OncologistsSunil Verma, Danielle Kerr-Cresswell, George Dranitsaris, et al.
Breast Cancer Research and Treatment|January 22, 2008
Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancerJoanne Kotsopoulos, William W Zhang, Shiyu Zhang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 12, 2020
Prediction of breast cancer-related outcomes with the Edmonton Symptom Assessment Scale: A literature reviewLauren Milton, Tara Behroozian, Natalie Coburn, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline-Taxane Chemotherapy in Early HER-2 Negative Breast CancerDanilo Giffoni de Mello Morais Mata, Rossanna C Pezo, Kelvin K W Chan, et al.
Clinical Breast Cancer|September 7, 2024
Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant ChemotherapyNeda Stjepanovic, Sudhir Kumar, Katarzyna J Jerzak, et al.
Pageof 11